Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
SUPER HI HDL Stock Losers Today 371 20260416 Paychex PAYX Support Levels Paychex Inc notches narrow EPS beat on solid payroll demand The competitive edge that makes SITE Centers SITC special Risk Aversion 20260508 JPC Nuveen reports sharp Q1 2026 year over year revenue drop shares edge up 013 percent today MOMO Hello reports sharp Q4 2025 EPS miss and 12 yearoveryear revenue drop shares dip slightly The competitive edge that makes National EYE special 113 20260511 Is Sensei Biotherapeutics SNSE stock relatively low risk Market Focus 20260422 Global Trade Update Highlights Growing Costs of NonTariff Measures in 2026 Farmers FMNB Fell 130 Is a Recovery Ahead 20260515 New Zealand Home Prices Edge Lower in April as Living Costs Weigh on Affordability Tecogen TGEN Q1 2026 Earnings Beat Revenue NA EPS 007 Why Koppers Holdings KOP Just Dropped 515 What to Watch 20260519 What PGIM High ISDs 069 Decline Means for Investors 20260518 Barclays Reports 18 Profit Increase Raises FullYear Income Guidance Consumer Faces 2700 Annual Interest on 13000 Credit Card Debt Despite 19000 Savings NatWest Group Receives Analyst Upgrade from BNP Paribas Signals Growing Confidence Qualcomm Stock Surges as Investors Wake Up to AI Device Boom Potential NASA Selects Blue Origin Over SpaceX for Critical Moon Base Mission CNBC Investing Club Highlights Top and Bottom Performers During SixWeek Market Rally RILYL Q1 2024 Earnings Preferred Stock Reports Net Loss No Revenue Disclosure Amidst Market Headwinds TAL Q1 2026 Earnings Massive EPS Beat Amidst Revenue Uncertainty TGS Q1 2026 Earnings Earnings Smash Estimates Amidst Energy Sector Dynamics JOE Q1 2026 Earnings EPS of 024 Reported Stock Declines Slightly MSIF Q1 2026 Earnings EPS Misses Estimates Amid Slight Stock Decline GGR Q1 2026 Earnings EPS Reports 048 as Gogoro Navigates Challenges Werewolf Therapeutics HOWL Stages a Modest Rebound Can the 044 Level Hold ENDRA Life Sciences NDRA Shows Modest Gains Testing Resistance at 573 Central Plains Bancshares CPBI Trades Flat Near 1857 Key Levels in Focus Lamar Advertising LAMR Edges Higher as Investors Eye Key Resistance Level Galmed Pharmaceuticals GLMD Surges 95 Testing Key Resistance at 071 Professional Title Youth Job Market Tightens Graduates Face Record Competition as Applications Surge Crude Oil Futures Slide as Diplomatic Efforts to Reopen Strait of Hormuz Gain Momentum NIO Stock Gains 93 After ES9 Launch Market Awaits May Delivery Data Rafael Devers Switches Agents Amid Trade Rumors Following Giants Acquisition Anthropic Overtakes OpenAI as Most Valuable AI Startup Valuation Approaching 1 Trillion US Jobless Claims Fall to Lowest Level Since MidMay Navigating Home Equity Loans with LessThanPerfect Credit Key Strategies SK Hynix Reports Record Profit in Q4 2024 Driven by AI Chip Demand EScooter Casualties Rise Sharply in Great Britain Nearly 500 Seriously Injured in 2025